The following clinical paper is available to you free of charge. If you wish to access, please select "View Document" and follow the instructions on the publishers website.
BMJ Open Gastroenterology
Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
A study aimed to compare the clinical and cost-effectiveness of tofacitinib with biological therapies.
This clinical paper has been certified by Pfizer Ltd. in accordance with the ABPI Code of Practice. This article contains promotional information and is intended for UK healthcare professionals.
PP-XEL-GBR-2270. August 2020